OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ACIU

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

AC Immune SA (ACIU) Earnings Date & Reports

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

ACIU is expected to report earnings to fall 5.95% to -19 cents per share on November 14

AC Immune SA ACIU Stock Earnings Reports

Q3'25

Est.

$-0.20

Q2'25

Missed

by $0.04

Q1'25

Beat

by $0.01

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.19

The last earnings report on August 05 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 97.92K shares outstanding, the current market capitalization sits at 215.28M.

View a ticker or compare two or three

Compare

ACIU

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACIU
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACIU showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

EPFL Innovation Park

Phone

+41 213459121

Employees

161

Web

https://www.acimmune.com